Compounded Sterile Preparations Pharmacy Specialty Certification: Intensive Studies Module 2 (L269141)

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in compounded sterile preparations pharmacy.

Board certified pharmacists are eligible to receive up to 4.0 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.   

ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.

ASHP is approved by BPS as a provider for the recertification of BCSCP.

When Hazardous Drugs are Sterile
ACPE #: 0204-0000-26-125-H07-P

• Differentiate the hazardous drug issues that are contained in USP <797> from those requirements in USP <800>.
• Suggest modifications to hazardous drug facilities that address common challenges  
• Choose appropriate procedures for hazardous drugs that could be entity-exempt in an Assessment of Risk.  

This activity is approved for Board Certified Sterile Compounding Pharmacist (BCSCP) recertification credit. 

483 Shades of Risk: Evaluating 503Bs for Health System Leaders
ACPE #: 0204-0000-26-139-H07-P

• Describe the rationale and evolving landscape for health-system pharmacy leaders to evaluate 503B outsourcing facilities. 
• Interpret FDA inspection documents and classifications (e.g., Form 483, Warning Letter, FMD-145, NAI/VAI/OAI) to determine vendor risk.
• Apply a standardized framework to evaluate 503B outsourcing facilities’ alignment with health-system SOPs, documentation, and stakeholder communication.

This activity is approved for Board Certified Sterile Compounding Pharmacist (BCSCP) recertification credit. 

The Invisible Shield: Aseptic Practices in Sterile Compounding
ACPE #: 0204-0000-26-130-H07-P

• Identify aseptic principles and their role in sterile compounding.
• Evaluate potential contamination sources and prevention strategies.
• Propose corrective actions in response to breaches in aseptic technique.

This activity is approved for Board Certified Sterile Compounding Pharmacist (BCSCP) recertification credit. 

Media Fills Unlocked: Practical Insights for Success
ACPE #:  0204-0000-26-133-H07-P

• Describe elements of media fills listed in the USP standard.
• Develop media fill procedures for staff administering the assessments.
• Recommend adjustments to existing media fill plans during  shortages of products or personnel. 

This activity is approved for Board Certified Sterile Compounding Pharmacist (BCSCP) recertification credit.

Full faculty bios 

Erika Anderson, CPhT, CSPT, BCSCPT
System Manager, Pharmacy Compounding
CommonSpirit Health 

Cindy Brasher, PharmD, MS, BCSCP
Manager of Compounding
St. Jude Children's Research Hospital 

Shannon Buxell, PharmD, MPH, BCSCP
Director, System Pharmacy Operations & Regulatory
Providence Health System 

Ashley Duty, PharmD, MS, BCSCP, FASHP
Director of Inpatient Pharmacy OperationsNationwid
e Children's Hospital 

Kevin N. Hansen, PharmD, MS, BCSCP
Director, 503B Program
Premier

Patricia C. Kienle, RPh, MPA, BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health 

Abby Roth, BS, CMQ/OE
Owner, Microbiologist
Pure Microbiology, LLC

Sue Dombrowski, MS, RPh
Angela Cassano, PharmD, BCPS*
Kevin N. Hansen, PharmD, MS, BCSCP*
Patricia C. Kienle, RPh, MPA, BCSCP, FASHP*

*Content Matter Experts

Raymond Antypas, PharmD, MPH, BCSCP
Mark Barricklow, RPH, BCSCP
Tara Breuer, RPh, BCPS, BCSCP
Melissa Chase, PharmD, BCSCP, CPEL
Michael Freudiger, PharmD, APh, BCPS, BCSCP
Varsha Gaitonde, PharmD, PhD
Bridget Gegorski, PharmD, MS, BCSCP
Justin Hair, PharmD, BCPS, ANP
Maha Hassan, BCSCP, MSc
Allison Hoff, BS Pharm
Melanie A. Horn, PharmD, BCSCP
Julia Huebner, PharmD, BCSCP
Justin Hair Justin Hair, PharmD, BCSCP, ANP
Amanda Lang, PharmD BCSCP BPS
Daisy Leong, PharmD, BCPS, BCSCP
Richard Martin, PharmD, BCSCP
James Mason, PharmD, MS, BCSCP
Kristen McCloy, PharmD, BCSCP, IgCP
Helen McKnight, PharmD, MBA, BCSCP
Rosanna Ressing, PharmD, RPh, BCSCP
Jocelyn Reynoso, PharmD, BCPS, BCGP, BCSCP
Arpita Sammons, PharmD, BCSCP
Elizabeth Schar, BS Pharm, DPLA, BCSCP
Julie Uyemura, PharmD, BCSCP
Tyler Vest, PharmD, MS, MSSCM, BCPS, BCSCP, FNCAP
Thuy Khanh Vu, PharmD, BCSCP
Allison Young, PharmD, MS, BCSCP

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessments
• Complete the evaluations 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

These activities were developed by ASHP.